Company Name: |
Varanous Labs Pvt Ltd
|
Tel: |
+91-7036248882 +91-7036248882 |
Email: |
bheemashankar.e@varanouslabs.com |
Products Intro: |
Product Name:Ivacaftor carboxylate CAS:1246213-24-0 Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:Ivacaftor Impurity 1 CAS:1246213-24-0 Purity:> 95% Remarks:an impurity of Ivacaftor
|
|
| Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl- Basic information |
Product Name: | Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl- | Synonyms: | Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl-;Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-alpha,alpha-diMethyl-;2-(5-tert-butyl-2-hydroxy-4-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl)-2-methylpropanoic acid;Ivacaftor Carboxylic Acid;2-[5-tert-butyl-2-hydroxy-4-[(4-oxo-1H-quinoline-3-carbonyl)amino]phenyl]-2-methylpropanoic acid;Ivacaftor Impurity 1;Ivacaftor Carboxylic Acid Impurity;Ivacaftor carboxylate | CAS: | 1246213-24-0 | MF: | C24H26N2O5 | MW: | 422.48 | EINECS: | | Product Categories: | | Mol File: | 1246213-24-0.mol | |
| Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl- Chemical Properties |
Melting point | >213°C (dec.) | Boiling point | 624.1±55.0 °C(Predicted) | density | 1.299±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO (Slightly), Methanol (Slightly) | form | Solid | pka | 4.33±0.16(Predicted) | color | White to Light Yellow |
| Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl- Usage And Synthesis |
Uses | Ivacaftor Carboxylic Acid is an impurity of Ivacaftor (I940600); a drug used in the treatment of cystic fibrosis. |
| Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethyl- Preparation Products And Raw materials |
|